AEON Biopharma | 8-K: Current report
AEON Biopharma | 8-K: Current report
AEON Biopharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
AEON Biopharma | 8-K: Current report
AEON Biopharma | 8-K: AEON Biopharma Reports First Quarter 2024 Financial Results
AEON Biopharma | DEFA14A: Others
AEON Biopharma | 8-K: Current report
AEON Biopharma | 8-K: Current report
AEON Biopharma | DEF 14A: Definitive information statements
AEON Biopharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
AEON Biopharma | 8-K: Current report
AEON Biopharma | 8-K: Current report
AEON Biopharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
AEON Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
AEON Biopharma | 8-K: Current report
AEON Biopharma | 8-K: AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
AEON Biopharma | 8-K: Current report
AEON Biopharma | 8-K: Current report
AEON Biopharma | 8-K: Current report
AEON Biopharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
No Data